美国非酒精性脂肪性肝病伴晚期纤维化负担显著:2011-2014年全国健康与营养调查的横断面分析
年龄增长、肥胖和并发糖尿病与≥F3纤维化风险升高相关。
要点
- 年龄增长、肥胖和并发糖尿病与≥F3纤维化风险升高相关。
核心结论
- 年龄和代谢综合征组分与纤维化风险升高独立相关。
研究设计与样本
- 横断面研究,使用2011-2014年美国全国健康与营养调查数据,该调查为全国分层多阶段抽样的非机构化美国成人(年龄≥20岁)调查。
- NAFLD患者中METAVIR F2或以上纤维化通过AST血小板比率指数(APRI)评分>0.7评估。
- METAVIR F3或以上纤维化通过NAFLD纤维化评分(NFS)>0.676和FIB-4评分>3.25评估。
- 采用多因素logistic回归模型评估NAFLD患者中纤维化的预测因素。
主要发现
- 多因素回归分析显示,年龄增长、肥胖和并发糖尿病与≥F3纤维化风险升高相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease in the US. Understanding the epidemiology of NAFLD, with specific focus on individuals with hepatic fibrosis is important to guide healthcare resource planning. AIM: To evaluate prevalence and predictors of hepatic fibrosis among US adults with NAFLD. METHODS: We performed a cross-sectional study using data from the updated 2011-2014 National Health and Nutrition Examination Survey, a national, stratified, multistage sampling survey of non-institutionalised US adults age ≥ 20. METAVIR F2 or greater fibrosis among individuals with NAFLD was assessed using AST to Platelet Ratio Index (APRI) score > 0.7. METAVIR F3 or greater fibrosis was assessed using NAFLD fibrosis score (NFS) > 0.676 and FIB-4 score > 3.25. Multivariate logistic regression models evaluated for predictors of fibrosis among individuals with NAFLD. RESULTS: Overall prevalence of NAFLD among US adults was 21.9% (95% CI 20.6-23.3), representing 51.6 million adults. Among individuals with NAFLD, we observed a 23.8% prevalence of ≥F2 fibrosis, representing 12.2 million individuals, and we observed a 2.3%-9.7% prevalence of ≥F3 fibrosis, representing as many as 5.0 million adults. On multivariate regression analyses, increasing age, obesity and concurrent diabetes mellitus were associated with increased risk of ≥F3 fibrosis. CONCLUSIONS: NAFLD represents a major healthcare burden among US adults with as many as 5 million adults estimated to have NAFLD with ≥F3 fibrosis. Age and the components of the metabolic syndrome are independently associated with higher risk of fibrosis.
引用
- Wong RJ, Liu B, Bhuket T, et al. Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey. Aliment Pharmacol Ther. 2017. PMID: 28914448. doi:10.1111/apt.14327
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。